Outcomes of intravesical Bacillus Calmette-Guerin in patients with non-muscle invasive bladder cancer: a retrospective study in Australia
IntroductionInduction intravesical Bacillus Calmette-Guerin (BCG) followed by maintenance after transurethral resection of bladder tumor, is the standard adjuvant therapy for high-risk non-muscle invasive bladder cancer (NMIBC). There is sparse evidence on the practice of intravesical BCG in Austral...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2024-02-01
|
| coleção: | Frontiers in Urology |
| Assuntos: | |
| Acesso em linha: | https://www.frontiersin.org/articles/10.3389/fruro.2024.1309532/full |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
